Creative Biolabs

Creative Biolabs introduces innovative solutions for live biotherapeutics to empower scientists and pharmaceutical companies in their quest for groundbreaking therapies against gut diseases.

Creative Biolabs is proud to announce the opening of applications for its 2024 scholarship program.

Creative Biolabs introduced the discovery of biomolecular approaches targeting Plasmodium, aiming to assist academia and the pharmaceutical industry in relieving the malaria health crisis.

Creative Biolabs is proud to announce its new-year resolution to dive deeper into sourcing professional animal model solutions for neurological disorder studies.

With the spotlight on mRNA vaccines post the prestigious Nobel Prize in Physiology or Medicine 2023, Creative Biolabs stands poised to revolutionize this groundbreaking technology.

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Biolabs updated its NAA solution, which was designed to provide invaluable insights into autoimmune diseases and autoantibody profiling and promises to propel the field of

Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.

Creative Biolabs updated strategies in order to help achieve success in immunotherapy discovery.

A newly released market research reports on the prosperous future of exosome research.